title: Safety concerns blight promising cancer therapy.
authors.forename: Heidi
authors.initials: H
authors.lastname: Ledford
mesh_terms: D000951:Antigens, Neoplasm / Q000276:immunology; D002986:Clinical Trials as Topic; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects* / Q000191:economics / Q000331:legislation & jurisprudence; D007938:Leukemia / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D008545:Melanoma / Q000628:therapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D061214:Patient Safety / Q000331:legislation & jurisprudence; D013601:T-Lymphocytes / Q000276:immunology / Q000637:transplantation*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
chemical_list: D000951:Antigens, Neoplasm